2Busch MP. Should HBV DNA NAT replace HBsAg and/or anti- HBc screening of blood donors [ J ]. Transfus Clin Biol, 2004,11( 1 ) :26-32
3Biswas R,Tabor E, Hsia CC,et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection[ J]. Transfusion ,2003,43 (5) :788-798
6Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas[J]. Vox Sang,2006,91 ( 1 ) :1-12
7Nantachit N,Thaikruea L, Thongsawat S, et al. Evaluation of a multiplex human immunodeficieney virus-I, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand [ J ]. Transfusion, 2007,47 ( 10 ) : 1803-1808
8Soedarmono YSM ,Suyati MF, Purwati LB, et al. Nucleic acid testing of first time Indonesian blood donors[ J]. Vox Sang,2005,89 (S2) :24
7Busch M P.Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors[J].Transfus Clin Biol,2004,11(1):26-32.
8WHO. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of hu- man blood plasma produets[M]. WHO Technieal Re- port, Series No. 924, 2004:10.
9Brechot C, Thiers V, Kremsdorf D, et al. Persistent hepatitis B virus in-fection in subjects without hepati- tis B surface antigen~ clinically signifi-cant of purely "occult"[J]. Hepatology, 2001,34(1) : 194-203.
10Aubuchon JP. Birkmeyer JD. Busch MP,et al. Cost-ef- fectiveness of expanded human immuno-deficieeney virus-testing protocols for donated blood[J]. Transfu- sion,1997,37(1) :45-51.
